Rankings
▼
Calendar
NERV FY 2016 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena
NERV
Minerva Neurosciences, Inc.
$51M
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$16,530
Operating Income
-$30M
Net Income
-$31M
EPS (Diluted)
$-7.88
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$133M
Total Liabilities
$27M
Stockholders' Equity
$106M
Cash & Equivalents
$83M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$16,530
-$17,276
+4.3%
Operating Income
-$30M
-$26M
-15.6%
Net Income
-$31M
-$27M
-14.6%
← Q4 2015
All Quarters
Q1 2016 →